Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1

Status

Recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 2Other neoplasm 1

Conditions

Malignant Neoplasms of Independent (Primary) Multiple Sites 1Gastrointestinal Neoplasms 1Gastrointestinal Malignancy 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Electrocardiography, Ambulatory × Clear all
NCT07456852 2026-06-02

Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

Mayo Clinic

Phase 1/2 Recruiting
60 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

NCT06538610 2024-12-09

The 5-FU Holter Study

University of Auckland, New Zealand

Phase NA Recruiting
10 enrolled
Gastrointestinal

Gastrointestinal Malignancy

NCT03177681 2023-03-27

The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms

M.D. Anderson Cancer Center

Phase NA Withdrawn
Other neoplasm

Malignant Neoplasms of Independent (Primary) Multiple Sites

Data powered by HemOnc (CC BY 4.0) Colophon âš¡